Digital SPR Opportunity Nicoya recently launched a Digital SPR platform combining premium performance with unprecedented accessibility, signaling growth potential for bundled instrument and consumable sales, software licenses, and service packages to biopharma and academic customers.

Cartridge & Reagent Expansion The introduction of Streptavidin cartridges alongside existing Carboxyl cartridges opens a cross-sell path for consumables and assay kits, enabling a recurring revenue stream from laboratories adopting Nicoya’s biosensor workflows.

AAV Research Support Launch of AAVX and AAV9 Capture Kits positions Nicoya to capture the gene therapy research market, offering capture kits and protocols that align with current trends in viral vector research and therapeutic development.

Automation Partnerships Strategic integrations with Labman Automation and Opentrons indicate a strong channel for automated sampling platforms and pre-configured workflows, suggesting co-sell opportunities for turnkey automation solutions and accelerated data yield.

Acquisition & Growth Acquisition of Applied Photophysics and ongoing equipment expansions imply a broadened product portfolio and stronger technical capabilities, creating upsell opportunities for higher-end instruments, service contracts, and integrated analytics.